{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:12:16Z","timestamp":1789229536587,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST108-2314-B-002-116-MY3"],"award-info":[{"award-number":["MOST108-2314-B-002-116-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST110-2314-B-002-093-MY3"],"award-info":[{"award-number":["MOST110-2314-B-002-093-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tice.2024.102479","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T01:56:12Z","timestamp":1721008572000},"page":"102479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin"],"prefix":"10.1016","volume":"89","author":[{"given":"Ding-Cheng","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Ping","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Tsan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing-Hwa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2024.102479_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13202","article-title":"Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle","volume":"19","author":"Abdulla","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.tice.2024.102479_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MNH.0b013e3283451901","article-title":"Mouse models of diabetic nephropathy","volume":"20","author":"Alpers","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.tice.2024.102479_bib3","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.2337\/dc19-S012","article-title":"12. Older adults: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.tice.2024.102479_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1114","article-title":"Impact of metformin on statin-associated myopathy risks in dyslipidemia patients","volume":"11","author":"Bak","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.tice.2024.102479_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00125-021-05415-5","article-title":"Defining the underlying defect in insulin action in type 2 diabetes","volume":"64","author":"Batista","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.tice.2024.102479_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2020.08.004","article-title":"Diabetic kidney disease","volume":"47","author":"Bonner","year":"2020","journal-title":"Prim. Care"},{"key":"10.1016\/j.tice.2024.102479_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2957","article-title":"Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes","volume":"34","author":"Bouchi","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tice.2024.102479_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2004080648","article-title":"Mouse models of diabetic nephropathy","volume":"16","author":"Breyer","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tice.2024.102479_bib9","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes","volume":"27","author":"Buse","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tice.2024.102479_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tem.2016.03.017","article-title":"Perspectives in GLP-1 research: new targets, new receptors","volume":"27","author":"Cantini","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"7795","key":"10.1016\/j.tice.2024.102479_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tice.2024.102479_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrd1828","article-title":"Exenatide","volume":"4","author":"Davidson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tice.2024.102479_bib13","doi-asserted-by":"crossref","first-page":"F1519","DOI":"10.1152\/ajprenal.00211.2018","article-title":"GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-side","volume":"315","author":"Dieter","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.tice.2024.102479_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9084567","article-title":"Exendin-4 improves diabetic kidney disease in C57BL\/6 mice independent of brown adipose tissue activation","volume":"2020","author":"Fang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.tice.2024.102479_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tice.2024.102479_bib16","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","article-title":"PI3K\/Akt and apoptosis: size matters","volume":"22","author":"Franke","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tice.2024.102479_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signaling pathway and cancer.","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tice.2024.102479_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ki.2013.427","article-title":"The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential","volume":"85","author":"Fujita","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.tice.2024.102479_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.tice.2024.102479_bib20","article-title":"Grip strength is potentially an early indicator of age-related decline in mice","volume":"6","author":"Ge","year":"2016","journal-title":"Pathobiol. Aging Age Relat. Dis."},{"key":"10.1016\/j.tice.2024.102479_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3070","article-title":"Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?","volume":"35","author":"Gentilella","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"10","key":"10.1016\/j.tice.2024.102479_bib22","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.3390\/jcm12103377","article-title":"Nephroprotective properties of antidiabetic drugs","volume":"12","author":"Gerdes","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.tice.2024.102479_bib23","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/ijms21103587","article-title":"Revisiting experimental models of diabetic nephropathy","volume":"21","author":"Giralt-Lopez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102479_bib24","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s00125-023-05988-3","article-title":"Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy","volume":"66","author":"Goldney","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.tice.2024.102479_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154044","article-title":"Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents","volume":"103","author":"Gurjar","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.tice.2024.102479_bib26","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1002\/jcb.27852","article-title":"Beneficial effects of metformin on muscle atrophy induced by obesity in rats","volume":"120","author":"Hasan","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.tice.2024.102479_bib27","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.metabol.2012.03.002","article-title":"GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases","volume":"61","author":"Hendarto","year":"2012","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.tice.2024.102479_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124952","article-title":"Hyperglycemia induces skeletal muscle atrophy via a WWP1\/KLF15 axis","volume":"4","author":"Hirata","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.tice.2024.102479_bib29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jcsm.12434","article-title":"Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy","volume":"10","author":"Hong","year":"2019","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.tice.2024.102479_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jdi.12328","article-title":"New mechanisms of metformin action: focusing on mitochondria and the gut","volume":"6","author":"Hur","year":"2015","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.tice.2024.102479_bib31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0006-2952(01)00924-8","article-title":"Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1","volume":"63","author":"Idris","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.tice.2024.102479_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/nu13010183","article-title":"A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.tice.2024.102479_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1345\/aph.1E245","article-title":"Incretin mimetics as emerging treatments for type 2 diabetes","volume":"39","author":"Joy","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tice.2024.102479_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4093\/dmj.2016.40.3.211","article-title":"Renoprotective effect of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in streptozotocin-induced type 1 diabetic mice","volume":"40","author":"Jung","year":"2016","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.tice.2024.102479_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tice.2024.102479_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcsm.12833","article-title":"Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a","volume":"13","author":"Kang","year":"2022","journal-title":"J. Cachex.\u00a0Sarcopenia Muscle"},{"key":"10.1016\/j.tice.2024.102479_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ndt\/gfu405","article-title":"Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease","volume":"31","author":"Karalliedde","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tice.2024.102479_bib38","doi-asserted-by":"crossref","first-page":"21962","DOI":"10.18632\/aging.203546","article-title":"Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice","volume":"13","author":"Khin","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.tice.2024.102479_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.npep.2018.11.004","article-title":"PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice","volume":"73","author":"Kjaergaard","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.tice.2024.102479_bib40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"Kodera","year":"2011","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.tice.2024.102479_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo13050655","article-title":"Resveratrol alleviates advanced glycation end-products-related renal dysfunction in D-galactose-induced aging Mice","volume":"13","author":"Lan","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.tice.2024.102479_bib42","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2337\/dc11-1032","article-title":"Insulin sensitizers may attenuate lean mass loss in older men with diabetes","volume":"34","author":"Lee","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tice.2024.102479_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory effects of GLP-1-Based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.tice.2024.102479_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166508","article-title":"The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice","volume":"1868","author":"Lyu","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.tice.2024.102479_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116738","article-title":"The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes","volume":"234","author":"Marques","year":"2019","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.tice.2024.102479_bib46","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/cells10081958","article-title":"The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: current evidence and underlying mechanisms","volume":"10","author":"Massimino","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tice.2024.102479_bib47","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/db11-1824","article-title":"Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCbeta activation in diabetes","volume":"61","author":"Mima","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tice.2024.102479_bib48","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.clinthera.2008.08.006","article-title":"Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study","volume":"30","author":"Moretto","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tice.2024.102479_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tice.2024.102479_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajpath.2012.09.016","article-title":"Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression","volume":"182","author":"Ojima","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tice.2024.102479_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1681\/ASN.2006070778","article-title":"Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db\/db mice","volume":"18","author":"Park","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tice.2024.102479_bib52","first-page":"94","article-title":"Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise","volume":"22","author":"Perry","year":"2016","journal-title":"Exerc. Immunol. Rev."},{"key":"10.1016\/j.tice.2024.102479_bib53","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S381546","article-title":"An effective glucagon-like peptide-1 receptor agonists, semaglutide, improves sarcopenic obesity in obese mice by modulating skeletal muscle metabolism","volume":"16","author":"Ren","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.tice.2024.102479_bib54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.tice.2024.102479_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.tice.2024.102479_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1275266","article-title":"Mechanisms and effects of metformin on skeletal muscle disorders","volume":"14","author":"Shang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tice.2024.102479_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917113","article-title":"Diabetic muscular atrophy: molecular mechanisms and promising therapies","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tice.2024.102479_bib58","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/1753-0407.12969","article-title":"Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects","volume":"11","author":"Sloan","year":"2019","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tice.2024.102479_bib59","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1007\/s11033-023-08621-z","article-title":"Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy","volume":"50","author":"Talukdar","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tice.2024.102479_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14656560802611832","article-title":"Exenatide: clinical aspects of the first incretin-mimetic for the treatment of type 2 diabetes mellitus","volume":"10","author":"Wajcberg","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.tice.2024.102479_bib61","doi-asserted-by":"crossref","DOI":"10.1590\/s0102-865020190010000001","article-title":"An experimental study of exenatide effects on renal injury in diabetic rats","volume":"34","author":"Wang","year":"2019","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.tice.2024.102479_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/03008207.2022.2088365","article-title":"Metformin reduces myogenic contracture and myofibrosis induced by rat knee joint immobilization via AMPK-mediated inhibition of TGF-beta1\/Smad signaling pathway.","volume":"64","author":"Wang","year":"2023","journal-title":"Connect Tissue Res."},{"key":"10.1016\/j.tice.2024.102479_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07435800.2015.1015726","article-title":"Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats","volume":"41","author":"Wu","year":"2016","journal-title":"Endocr. Res."},{"key":"10.1016\/j.tice.2024.102479_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119300","article-title":"GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R\/AMPK pathway","volume":"1869","author":"Wu","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.tice.2024.102479_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105807","article-title":"Skeletal muscle atrophy: from mechanisms to treatments","volume":"172","author":"Yin","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tice.2024.102479_bib66","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2017.11.076","article-title":"Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats","volume":"495","author":"Yin","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tice.2024.102479_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13287-019-1480-x","article-title":"Metformin alleviates muscle wasting post-thermal injury by increasing Pax7-positive muscle progenitor cells","volume":"11","author":"Yousuf","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tice.2024.102479_bib68","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tice.2024.102479_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114958","article-title":"Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK\/mTOR-independent pathway","volume":"164","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2024.102479_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tice.2024.102479_bib71","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3892\/mmr.2014.2555","article-title":"Liraglutide ameliorates renal injury in streptozotocin\u2011induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor\u2011kappaB pathway.","volume":"10","author":"Zhou","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tice.2024.102479_bib72","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/15548627.2021.1956123","article-title":"Exendin-4 stimulates autophagy in pancreatic \u03b2-cells via the RAPGEF\/EPAC-Ca2+-PPP3\/calcineurin-TFEB axis","volume":"18","author":"Zummo","year":"2022","journal-title":"Autophagy"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624001800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624001800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:10:39Z","timestamp":1777457439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816624001800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":72,"alternative-id":["S0040816624001800"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2024.102479","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2024.102479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102479"}}